Clinical Pipeline Updates: Part 2

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This activity was planned to meet the educational needs of Pharmacists with an interest in new developments in multiple sclerosis, cardiovascular disease, rheumatology, and IT infrastructure. .

• List recently approved and upcoming agents for use in a variety of conditions, including multiple sclerosis, cardiovascular disease, and rheumatology.
• Identify characteristics of upcoming agents, including mechanism of action, dosing, adverse effects, clinical efficacy, patient counseling points, and special considerations for pharmacists.
• Explain the role of upcoming agents and new technology in the management of patients, including the niche in therapy.
• Summarize important considerations for pharmacists in the specialty and ambulatory care settings, including implementation of new technology, medication usage criteria, prior authorizations, and special handling or storage.

• Introduction and Announcements
• Presentation with self- assessment

Dr. Linda M. Spooner, Pharm.D., BCPS-AQ ID, FASHP, FCCP, Professor of Pharmacy Practice, Massachusetts College of Pharmacy and Health Science University, Boston, MA

Dr. James Coons, Pharm.D., BCCP, FACC, FCCP, Associate Professor, University of Pittsburgh, Pittsburgh, PA

Dr. Joseph Lassiter, Pharm.D., M.S., CPHIMS, President and Managing Advisor, The Robertson Group (TRG), Portland, OR

Dr. Bonnie LaTourette, Pharm.D., BCPS, Clinical Staff Pharmacist/Clinical Assistant Professor, Froedtert and The Medical College of Wisconsin, Milwaukee, WI

Dr. Jennifer Towle, Pharm.D., B.S., Assistant Professor Pharmacy Practice, MCPHS University, Boston, MA

In accordance with the ACPE's and ACCME's Standards for Commercial Support, anyone in a position to control the content of an educational activity is required to disclose to the accredited provider their relevant financial relationships. In accordance with these Standards, all potential conflicts of interest have been resolved. An individual has a relevant financial relationship if he or she (or spouse/domestic partner) has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the activity content over which the individual has control.

As defined by ACCME, a commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The Standards for Commercial Support do not consider providers of clinical service directly to patients to be commercial interests. The existence or non-existence of relevant financial relationships will be disclosed to the activity audience. All identified conflicts of interest must be resolved prior to the activity.

This activity consists of recordings of faculty slides presentations with embedded self- assessment. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP eLearning Portal. Follow the prompts online to complete the evaluation, claim credit, and view the statement of credit immediately after completing the activity.

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Claim your CE at http://elearning.ashp.org. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.